(January 6, 2016, 11:31 AM EST) -- PHILADELPHIA — A Third Circuit U.S. Court of Appeals panel on Jan. 5 affirmed that the statute of limitations in a thalidomide birth defect case began to run when the plaintiff’s mother learned of a possible connection between the morning sickness drug and birth defects and not when the plaintiff discovered the link in 2012 (Debra Johnson v. GlaxoSmithKline, LLC, et al., No. 15-2086, 3rd Cir.)....